Trial NCT04712357
Publication Arruda EAG, medRxiv (2021) (preprint)
Primary outcome on the report: The score of symptoms and predictive signs of COVID-19, assessed on the seventh day of patient follow-up / Two scores based on these symptoms (Table 4) were delineated as primary parameters and most associated with SARS-CoV-2 infection to assess efficacy of TDF and TDF combined with FTC in patients on the seventh day of COVID-19 evolution.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.